ArticleAnnals of medicine and surgery (2012)2026
Magnetic sphincter augmentation versus fundoplication for GERD: a systematic review and meta-analysis of postoperative outcomes.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gastroesophageal reflux disease (GERD) is commonly treated with surgical interventions such as magnetic sphincter augmentation (MSA) or fundoplication (FP). This meta-analysis evaluates postoperative outcomes of MSA versus FP in GERD management. Methods: A systematic literature search was conducted across PubMed, Cochrane Library, ScienceDirect, and Embase up to April 2025, identifying studies comparing MSA and FP for GERD. Pooled odds ratios (ORs) or mean differences (MDs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Heterogeneity was assessed with the Results: Twelve studies, published between 2014 and 2024, were included. No significant differences were observed in postoperative proton pump inhibitors (PPI) use (OR: 0.70, 95% CI: 0.30-1.67, Conclusions: MSA and FP demonstrate comparable efficacy in GERD symptom control, PPI use, and dysphagia. MSA offers significant advantages in preserving the ability to belch and vomit and reducing gas bloating. Substantial heterogeneity in GERD-HRQL scores, postoperative PPI use, dysphagia, and ability to vomit warrants cautious interpretation, and further studies are needed to optimize surgical approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.